共 18 条
[2]
BRODIE BB, 1949, J BIOL CHEM, V179, P25
[3]
CUMMINS LH, 1977, PEDIATRICS, V59, P144
[4]
DANAN G, 1981, J PHARMACOL EXP THER, V218, P509
[5]
DRAVET C, 1977, LANCET, V1, P810
[6]
INHIBITION OF MIXED-FUNCTION OXIDATIONS BY SUBSTRATES FORMING REDUCED CYTOCHROME-P-450 METABOLIC-INTERMEDIATE COMPLEXES
[J].
PHARMACOLOGY & THERAPEUTICS PART A-CHEMOTHERAPY TOXICOLOGY AND METABOLIC INHIBITORS,
1977, 2 (01)
:227-245
[7]
Hayton A C, 1969, N Z Med J, V69, P42
[8]
HINTON NORMAN A., 1959, ANTIBIOT AND CHEMOTHER, V9, P667
[9]
LAGIER G, 1979, THERAPIE, V34, P515
[10]
LEDAFNIET M, 1981, J PHARMACOL EXP THER, V219, P558